ResearcherEmory UniversityNo recent work listed

Ronica H. Nanda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3748-8674; OpenAlex author ID A5089165680. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability. Co-author DOI 10.1002/jso.23921 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jerome Carl Landry · 1 shared paper, 2015 · strength 0.07
- Paper Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectabilit… DOI 10.1002/jso.23921 ↗
Shishir Kumar Maithel · 1 shared paper, 2015 · strength 0.07
- Paper Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectabilit… DOI 10.1002/jso.23921 ↗
Bassel F. El‐Rayes · 1 shared paper, 2015 · strength 0.07
- Paper Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectabilit… DOI 10.1002/jso.23921 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.